Ni Lian

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Disease Activity

Top Venues

Cell death & disease

Dermatologic therapy

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

FangYuan Long, Xuecui Wei, Yujie Chen, Min Li, Ni Lian, Shanshan Yu, Sihan Chen, Yong Yang, Min Li, Heng Gu, Xu Chen
Gasdermin E promotes translocation of p65 and c-jun into nucleus in keratinocytes for progression of psoriatic skin inflammation. Cell death & disease 15 (3) (2024)
FangYuan Long, Xuecui Wei, Yujie Chen, Min Li, Ni Lian, Shanshan Yu, Sihan Chen, Yong Yang, Min Li, Heng Gu, Xu Chen
Gasdermin E promotes translocation of p65 and c-jun into nucleus in keratinocytes for progression of psoriatic skin inflammation. Cell death & disease 15 (3) (2024)
FangYuan Long, Xuecui Wei, Yujie Chen, Min Li, Ni Lian, Shanshan Yu, Sihan Chen, Yong Yang, Min Li, Heng Gu, Xu Chen
Gasdermin E promotes translocation of p65 and c-jun into nucleus in keratinocytes for progression of psoriatic skin inflammation. Cell death & disease 15 (3) (2024)
Ni Lian, Yujie Chen, Sihan Chen, Ying Zhang, Hao Chen, Yong Yang, Heng Gu, Qing Chen, Min Li, Xu Chen
Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis. Cell death & disease 14 (9) (2023)
Ni Lian, Yujie Chen, Sihan Chen, Ta Xiao, Changjun Song, Yangying Ke, Xuecui Wei, Chunyan Gong, Hui Yu, Heng Gu, Qing Chen, Min Li, Xu Chen
Necroptosis-mediated HMGB1 secretion of keratinocytes as a key step for inflammation development in contact hypersensitivity. Cell death discovery 8 (1) (2022)
Zhimin Hao, Ni Lian, Heng Gu, Min Chen
The diagnostic significance of PGGT1B in psoriasis. Dermatologic therapy 34 (2) (2021)
Ni Lian, Li Zhang, Min Chen
Tumor necrosis factors-α inhibition-induced paradoxical psoriasis: A case series and literature review. Dermatologic therapy 33 (6) (2020)
Liqing Shi, Ni Lian, Lihao Liu, Min Chen
Tapering and discontinuation of systemic medications in psoriasis patients with low disease activity. Dermatologic therapy 33 (4) (2020)